| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/18/1986 | US4571334 Composition for curing respiratory diseases |
| 02/13/1986 | WO1986000811A1 Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same |
| 02/13/1986 | WO1986000809A1 Prolonged storage of red blood cells |
| 02/11/1986 | US4569794 Process for purifying proteins and compounds useful in such process |
| 02/11/1986 | CA1200506A1 Caries inhibition |
| 02/11/1986 | CA1200489A1 Method of preparation of human urine origin colony- stimulating factor and kallikrein |
| 02/05/1986 | EP0170550A1 Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them |
| 02/05/1986 | EP0170115A1 Thrombus dissolvent |
| 02/04/1986 | US4568725 Products based on polymers or copolymers substituted by groups having selective affinity towards products involved in blood plasma coagulation and process for preparing same |
| 01/30/1986 | WO1986000639A1 Lymphokine production and purification |
| 01/30/1986 | WO1986000530A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/30/1986 | WO1986000529A1 An antiviral preparation and the method of its production |
| 01/30/1986 | WO1986000525A1 Process for the preparation of a pharmaceutical composition influencing the tissue metabolism and having a regenerating action |
| 01/30/1986 | WO1986000523A1 Dietary supplement and method of minimizing effects of infection through diet |
| 01/29/1986 | EP0169729A2 Recovery of cell receptors |
| 01/29/1986 | EP0169566A1 Novel CSF and method for obtaining the same |
| 01/22/1986 | EP0169114A2 Human alpha-1-antitrypin derivatives and process for their preparation |
| 01/22/1986 | EP0169016A2 Polypeptide cartilage-inducing factors found in bone |
| 01/22/1986 | EP0168506A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/21/1986 | US4565699 Composition of matter and process |
| 01/21/1986 | US4565697 Process for producing a hepatitis B infection preventing vaccine |
| 01/21/1986 | US4565652 Process for removing lipoproteins using derivatized polyhydroxymethylene |
| 01/21/1986 | US4565580 Substrate consisting of regenerated collagen fibrils and method of manufacturing same |
| 01/21/1986 | CA1199597A1 Process for the industrial preparation of collagenous materials from human placental tissues, collagenous materials thus obtained and applications thereof as biomaterials |
| 01/21/1986 | CA1199579A1 Process for the purification of physiologically active substance having antitumor activity |
| 01/16/1986 | WO1986000337A1 HUMAN alpha1-ANTITRYPSIN DERIVATIVES AND PREPARATION PROCESS THEREOF |
| 01/15/1986 | EP0168363A2 Sulfone activated thioether adsorbents for the separation of proteins and the like |
| 01/15/1986 | EP0168342A1 Process for the preparation of thrombin inhibitors |
| 01/15/1986 | EP0168217A2 Method of extracting tumor necrosis factor-like substance |
| 01/15/1986 | EP0168214A2 Tumor necrosis factor, methods for its preparation, compositions containing it, DNA encoding it and assay method using such DNA |
| 01/15/1986 | EP0168140A2 Purification apparatus and method employing a regenerable ligand |
| 01/15/1986 | EP0168093A1 Binder for low density lipoproteins |
| 01/15/1986 | EP0167834A2 Metal-containing polyaldehyde microspheres |
| 01/15/1986 | EP0167761A1 Anthracycline compounds and anticancer agents |
| 01/15/1986 | EP0167690A2 Droplet generation |
| 01/15/1986 | EP0167575A1 Cardiodilatine, a new peptide hormone and production process thereof. |
| 01/08/1986 | EP0167449A2 New ganglioside derivatives |
| 01/08/1986 | EP0167146A2 Primycin salts, method for their preparation and pharamaceutical preparations obtained |
| 01/08/1986 | EP0166996A1 A method for stabilizing a physiologically active substance produced by recombinant DNA technique and a stable aqueous solution or powder containing the same |
| 01/07/1986 | US4563350 Hypoimmunogenic osteogenic factor |
| 01/03/1986 | WO1986000078A1 Inhibin isolated from ovarian follicular fluid |
| 01/02/1986 | EP0166505A2 Isolation and quantitation of alkaline phosphatase |
| 01/02/1986 | EP0166325A2 Process and device for the selective separation of pathological and/or toxic species from blood or plasma with the use of filter candles |
| 01/02/1986 | EP0166324A2 Process for the selective precipitation of low-density lipoproteins |
| 12/31/1985 | US4562072 Heating solution in the presence of calcium ions, an amino acid, and a carbohydrate |
| 12/31/1985 | CA1198702A1 Method of culturing microbes belonging to the genus bordetella and culture medium |
| 12/31/1985 | CA1198695A1 Antibiotic compound |
| 12/31/1985 | CA1198672A1 Fibrinolytically active agent and a method for the preparation thereof |
| 12/27/1985 | EP0165912A2 Thioether adsorbent intended for the separation of proteins and the like |
| 12/27/1985 | EP0165726A2 Intestinal microflora-improving agent |
| 12/27/1985 | EP0165716A1 Simultaneous multiple assays and compositions useful therein |
| 12/27/1985 | EP0165709A2 Method of treating blood plasma to remove low density lipoproteins and very low density lipoproteins selectively |
| 12/27/1985 | EP0165606A2 Testing agent for b cell blastogenesis |
| 12/27/1985 | EP0165568A2 Process for the specific adsorption of heparin |
| 12/27/1985 | EP0165476A2 Tissue protein PP18, process for obtaining it and its use |
| 12/24/1985 | US4560774 Antineoplastic agents |
| 12/24/1985 | US4560649 Complexing with disulfide compound |
| 12/24/1985 | US4560509 Animal feeds-utilization efficiency |
| 12/24/1985 | US4560504 Carboxyl anchored immobilized antibodies |
| 12/24/1985 | CA1198366A1 Antihemophilic factor concentrate |
| 12/19/1985 | WO1985005629A1 Ltr vectors, methods of preparation and use |
| 12/19/1985 | WO1985005553A1 Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and profylactic treatment |
| 12/18/1985 | EP0165120A1 Lymphadenopathy-associated retrovirus adapted to continuous lymphoblastoid-B cell lines capable of continuously producing said retrovirus, and process for preparing the cell lines |
| 12/18/1985 | EP0164965A2 Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody |
| 12/17/1985 | US4559228 Composition and method for the treatment of cancer |
| 12/17/1985 | US4559222 Mineral oil polyisobutylene, colloidal silicon dioxide mixture; controlled release |
| 12/17/1985 | CA1198058A1 Biostimulating agent |
| 12/17/1985 | CA1198056A1 Inactivation of a lipid virus |
| 12/17/1985 | CA1198052A1 Region-specific determinants for vitamin k dependent bone protein |
| 12/17/1985 | CA1198051A1 Purified glycoproteins from cow, horse and sheep and use in diagnosing infectious mononucleosis |
| 12/11/1985 | EP0164036A1 Composition for accelerating recovery of function of hematopoietic organs and the use thereof |
| 12/11/1985 | EP0163638A1 Composition for supplemental treatment of male climacteric |
| 12/10/1985 | US4558035 Material for use in the treatment of spontaneous abortions |
| 12/10/1985 | US4558011 Method for preparation of pure hepatitis B surface antigen from human plasma |
| 12/10/1985 | US4557933 Antibiotic called "chloropolysporin", a process for its preparation, and its therapeutic and veterinary use |
| 12/10/1985 | US4557764 Process for preparing malleable collagen and the product thereof |
| 12/10/1985 | CA1197801A1 Preparation process immunostimulant proteoglycans inductors of interferon, proteoglycans thus obtained and drugs containing them |
| 12/10/1985 | CA1197798A1 Use of propionic bacteria |
| 12/10/1985 | CA1197780A1 Production of blood coagulation factor viii:c |
| 12/04/1985 | EP0163623A2 The use of a cell surface protein obtained from Staph. aureus |
| 12/04/1985 | EP0163218A2 Method for the production of human T-T cell hybridomas and production of suppressor factor by human T-T cell hybridomas |
| 12/04/1985 | EP0163146A1 Separation method, separation device and separation apparatus for separating body fluid into respective components |
| 12/04/1985 | EP0162977A2 Enzyme immunoassay for cancer procoagulant |
| 11/27/1985 | EP0162726A2 A natural inhibitor that protects against viral infections |
| 11/27/1985 | EP0162426A2 Process for obtaining a factor XIII preparation and its use |
| 11/27/1985 | EP0162078A1 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein. |
| 11/26/1985 | US4555402 Physiologically active substance K-252, process for producing same and pharmaceutical composition containing same |
| 11/21/1985 | WO1985005034A1 Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions |
| 11/21/1985 | WO1985005033A1 Stabilized mussel extract |
| 11/21/1985 | WO1985005031A1 A method for the modulation of the immune response |
| 11/21/1985 | EP0162032A2 Novel atrial peptide |
| 11/21/1985 | EP0161937A2 Recombinant fusion proteins |
| 11/21/1985 | EP0161849A2 Cl-1724 antibiotic-antitumour compounds, pharmaceutical compositions comprising the compounds and a novel microorganism for producing the compounds |
| 11/21/1985 | EP0161640A2 Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo |
| 11/21/1985 | EP0161384A2 Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same |
| 11/19/1985 | US4554162 CL-1724 Antibiotic compounds, their production and use |
| 11/19/1985 | US4554161 Dermatic medicament |
| 11/19/1985 | US4553974 Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor |
| 11/13/1985 | EP0161000A2 Human suppressor factors and method of using them |
| 11/13/1985 | EP0037394B1 A device for removal of substances from a liquid |